Liver Toxicity Screening Service - Creative Biogene Zebrafish Platform

Hepatotoxicity Assessment in Zebrafish

Early detection of drug-induced liver injury

Drug-induced liver injury (DILI) remains a leading cause of attrition during both early and late-stage drug development, as well as post-marketing withdrawals. Conventionalin vitro models often lack systemic metabolism, while rodent studies require larger compound amounts and longer timelines, creating a gap in high-throughput, physiologically relevant screening.

Zebrafish larvae offer a unique bridge: by 5 days post fertilization (dpf), the liver is fully developed and functional, with metabolic and detoxification pathways similar to those in humans. This in vivo model enables rapid, cost-effective assessment of hepatotoxicity, leveraging whole-organism biology including bile flow, enterohepatic circulation, and immune interactions.

Our service exposes wildtype zebrafish larvae to test compounds from 96 to 120 hours post fertilization, then quantifies liver necrosis, hepatomegaly, and hepatic steatosis using automated imaging and specific staining. The assay provides high concordance with mammalian data, allowing you to rank compounds, prioritize leads, and reduce attrition risk earlier in the pipeline.

Avoid late-stage DILI surprises Over 40% of drug candidates fail due to liver toxicity that was not detected early enough. Our zebrafish hepatotoxicity screening flags liabilities before costly preclinical and clinical stages.

Principle of the Assay

How zebrafish larvae model liver injury

Functional Liver by 5 dpf

By 5 days post fertilization, zebrafish larvae develop a fully functional liver expressing metabolic enzymes (e.g., cytochromes P450) and detoxification pathways homologous to those in humans. Bile circulation and enterohepatic transport are also operational.

Compound Exposure via Medium

Test compounds are added directly to the larval culture medium. Larvae absorb compounds through skin and gills, providing systemic exposure that mimics oral or intravenous administration in vivo. Exposure typically spans 24–72 hours from 96 to 120 or 144 hpf.

Liver-Specific Endpoints

After exposure, larvae are fixed and stained for visualization. Hepatic area is measured using fluorescent reporters or vital dyes, and lipid content in liver and yolk is quantified via specific fat staining (e.g., Nile Red or Oil Red O).

High-Throughput Readout

Larvae are arrayed in multi-well plates and imaged automatically. Custom algorithms segment the liver region, measure area, and classify steatosis, necrosis (boolean), and hepatomegaly per larva. Hundreds of compounds can be processed in a single run.

3Rs-Aligned Methodology

Zebrafish larvae up to 5 dpf are not classified as protected animals under EU /63/EU, reducing regulatory burden. The method replaces or reduces the use of mammalian models while providing in vivo metabolic context.

Liver Toxicity Endpoints Covered

Quantitative and qualitative readouts for comprehensive safety profiling

♥

Liver Necrosis

Boolean assessment of necrotic tissue based on altered morphology and loss of cellular integrity in the liver region.

▣

Hepatomegaly

Estimated liver area measured from fluorescent images; enlargement indicates toxic response or metabolic stress.

⌬

Hepatic Steatosis

Quantification of lipid accumulation in the liver using specific fat staining, a key indicator of drug-induced fatty liver disease.

⬢

General Hepatotoxicity Index

Combined scoring integrating necrosis, area change, and steatosis to provide an overall hepatotoxicity risk classification.

Model Comparison: Zebrafish vs. Alternatives

Why zebrafish larvae are the optimal choice for early hepatotoxicity screening

Feature	Zebrafish Larvae	Rodent In Vivo	2D Hepatocyte Culture	3D Liver Microtissues / Organoids
Systemic metabolism	Yes (whole organism)	Yes	No (unless co-cultured)	Partial (simplified bile flow)
Throughput (compounds/week)	High (hundreds of wells)	Low (10–20 max)	High (automated 384-well)	Moderate (48–96 well)
Time to result	Days (5 d exposure + imaging)	Weeks (1–3 month study)	Days (48–72 h assay)	1–2 weeks (culture + assay)
Compound amount needed	Micrograms (µM in medium)	Milligrams (oral gavage)	Micrograms (µM in plate)	Micrograms (µM in plate)
3Rs compliance	Reduces/replaces mammal use	Requires animal license	No animal use	May require animal-derived matrices
Automation capability	Fully automated imaging & analysis	Manual scoring / limited automation	Fully automated	Partially automated

Workflow

From compound to hepatotoxicity report in 5 days

1

Embryo Collection and Rearing

Wildtype zebrafish embryos are collected and maintained in standard conditions until 5 days post fertilization (dpf). At this stage the liver is fully developed, with functional metabolic pathways and detoxification enzymes, providing a mature model for toxicity testing.

Wildtype zebrafish larvae at 5 dpf with transparent body, allowing optical imaging of internal organs.

→

2

Compound Dosing and Exposure

Larvae are transferred to multi-well plates and exposed to test compounds at predetermined concentrations in the medium. Exposure lasts from 96 to 120 hpf (24 hours) or longer depending on study design, ensuring sufficient time for hepatotoxic effects to manifest.

Arrayed zebrafish larvae in a 96-well plate during compound exposure.

→

3

Hepatotoxicity Readout and Analysis

After exposure, larvae are fixed and stained with fluorescent dyes to visualize liver morphology and lipids. Automated imaging captures each larva; custom algorithms measure liver area (hepatomegaly) and fat content (steatosis), and classify necrosis. A final report summarizes all endpoints.

Representative images of healthy (left) and steatotic livers (right) after specific fat staining.

Bioinformatics and Data Analysis

Automated image processing and statistical reporting

Image Analysis Pipeline

Image Acquisition — High-throughput fluorescence microscopy captures brightfield and fluorescent channels (e.g., liver-specific reporter or vital dye) for each well.
Liver Segmentation — Custom algorithms identify the liver region based on intensity, shape, and position relative to the yolk and gut.
Morphometric Measurement — Liver area (pixels or µm²) is calculated and normalized to body length to account for size variation among larvae.
Steatosis Quantification — Lipid stain intensity in the liver is measured; a steatosis index is computed relative to positive and negative controls.
Necrosis Classification — Boolean classification (present/absent) based on irregular morphology, loss of fluorescence, or other tissue disruption features.
Statistical Reporting — Results are compared to vehicle and positive controls using ANOVA or non-parametric tests; a hepatotoxicity score is assigned per compound.

Report

Hepatotoxicity Screening Report

Per-larva measurements of liver area, steatosis index, and necrosis
Group summary statistics (mean ± SEM, fold-change vs. control)
Heatmap of individual compound effects with significance markers
Interpretation summary: hepatotoxicity risk category (low/moderate/high)

Data

Raw and Processed Data Set

Original microscopy images (TIFF/PNG) for all larvae
Segmented liver masks and area measurements
Steatosis intensity values per larva
Compiled Excel file with all endpoints ready for downstream analysis

Applications

Where zebrafish hepatotoxicity screening adds the most value

1

Lead Optimization

Rank structural analogues or candidate series by their hepatotoxicity profile to select the safest lead for further development. The high-throughput nature allows you to test tens of compounds per week.

2

Safety Profiling of Environmental Chemicals

Assess liver toxicity of agrochemicals, industrial compounds, or consumer product ingredients using a whole-organism model that captures metabolic activation and detoxification.

3

Early DILI Risk Assessment

Flag compounds that cause steatosis, necrosis, or hepatomegaly before investing in rodent studies. The assay's concordance with mammalian data supports confident go/no-go decisions.

4

Regulatory Submission Support

Supplementin vitro and rodent data with zebrafish evidence to strengthen the weight-of-evidence for hepatotoxicity risk assessment in IND or regulatory dossiers.

Sample Requirements

What we need to start your project

Project Type	Starting Material	Compound Amount	Turnaround
Single-compound toxicity profiling	Wildtype zebrafish larvae (provided by us)	≥ 5 mg or 50 µL of 10 mM stock	2–3 weeks from sample receipt
Multi-compound screening (cmpds)	Wildtype zebrafish larvae (provided by us)	≥ 5 mg or 50 µL per compound	3–4 weeks
Dose-response (3–5 concentrations)	Wildtype zebrafish larvae (provided by us)	≥ 25 mg total per compound	3–4 weeks
Custom study (e.g., co-exposure, time course)	Wildtype zebrafish larvae (provided by us)	Scoped per project	Determined per project

Deliverables

What you receive after project completion

Comprehensive hepatotoxicity report with per-larva data and statistical analysis

Quantified liver area (hepatomegaly) for each larva, normalized to body length

Steatosis index measured by specific fat staining intensity in the liver

Necrosis classification (present/absent) for each larva

Representative microscopy images showing liver morphology and lipid accumulation

Comparison to vehicle and positive controls, including fold-change and significance

Raw image files (TIFF format) and processed data export (Excel)

Detailed methods section suitable for internal reports or regulatory submission

Frequently Asked Questions

Common inquiries about zebrafish hepatotoxicity screening

How well do zebrafish liver toxicity results correlate with human outcomes?

Published studies demonstrate high concordance between zebrafish and mammals after exposure to known hepatotoxic and non-hepatotoxic compounds. The metabolic pathways and detoxification mechanisms in zebrafish larvae are homologous to those in humans, supporting translational relevance. However, as with any model, results should be interpreted alongside other safety data.

What liver-specific endpoints are measured?

We assess three primary endpoints: liver area (for hepatomegaly), lipid accumulation (steatosis), and necrosis (binary presence/absence). These cover the most common drug-induced liver injuries. All endpoints are quantified using automated imaging and validated staining protocols.

How many compounds can be screened in a single experiment?

The standard assay is performed in multi-well plates (96-well format), allowing dozens of compounds to be tested concurrently with appropriate controls. Throughput can be scaled per project needs; we recommend discussing your compound library size during consultation.

Is the zebrafish model considered an animal experiment?

Zebrafish larvae up to 5 days post fertilization are not classified as protected animals under EU /63/EU, reducing ethical and regulatory hurdles. However, local regulations may vary; we comply with all applicable guidelines and can provide documentation upon request.

What compound solubility or preparation requirements exist?

Compounds should be soluble in DMSO or the culture medium at the required final concentration (typically ≤1% DMSO). We provide compound handling instructions and will confirm feasibility before starting the study. For poorly soluble compounds, alternative dosing strategies (e.g., microinjection) may be considered.

Can this service be combined with other zebrafish toxicity endpoints?

Yes. Our ZeGlobalTox platform integrates hepatotoxicity, cardiotoxicity, and neurotoxicity readouts from the same larvae, maximizing data per compound. Contact us to design a multi-endpoint study that fits your needs.